3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases

Sebastian Schloera Institute-Associated Research Group “Regulatory Mechanisms of Inflammation”, Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Center, University of Münster, Münster, Germany;b Leibniz Institute of Virology, Hamburg, GermanyView further author information

Daniel Treuherza Institute-Associated Research Group “Regulatory Mechanisms of Inflammation”, Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Center, University of Münster, Münster, GermanyView further author information

Aileen Faistc Institute of Virology, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Center, University of Münster, Münster, GermanyView further author information

Marlous de Wittc Institute of Virology, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Center, University of Münster, Münster, GermanyView further author information

Katharina Wunderlichc Institute of Virology, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Center, University of Münster, Münster, GermanyView further author information

Rainer Wiewrodtd Department of Medicine A, Hematology, Oncology and Respiratory Medicine, University Hospital Münster, Münster, GermanyView further author information

Karsten Wiebee Department of Thoracic Surgery, University Hospital Münster, Münster, GermanyView further author information

Peter Barthf Gerhard-Domagk-Institute of Pathology, Westfälische Wilhelms-University, Münster, GermanyView further author information

Joo-Hee Wälzleing Center for Biological Threats and Special Pathogens, Robert Koch-Institute, Berlin, GermanyView further author information

Susann Kummerg Center for Biological Threats and Special Pathogens, Robert Koch-Institute, Berlin, GermanyView further author information

Anne Balkema-Buschmannh Friedrich-Loeffler-Institute, Institute of Novel and Emerging Infectious Diseases, Greifswald, Germany

https://orcid.org/0000-0001-7613-9592 View further author information

Stephan Ludwigc Institute of Virology, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Center, University of Münster, Münster, Germany

https://orcid.org/0000-0003-4490-3052 View further author information

Linda Brunottec Institute of Virology, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Center, University of Münster, Münster, Germany

https://orcid.org/0000-0001-8074-7400 View further author information

Ursula Reschera Institute-Associated Research Group “Regulatory Mechanisms of Inflammation”, Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation, and “Cells in Motion” Interfaculty Center, University of Münster, Münster, GermanyCorrespondence[email protected]

https://orcid.org/0000-0001-8892-319X View further author information

show all

3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date